The diverse roles of tnni3k in cardiac disease and potential for treatment

Caroline Pham, Noelia Muñoz‐martín, Elisabeth M. Lodder

Research output: Contribution to JournalReview articleAcademicpeer-review

1 Citation (Scopus)


In the two decades since the discovery of TNNI3K it has been implicated in multiple cardiac phenotypes and physiological processes. TNNI3K is an understudied kinase, which is mainly expressed in the heart. Human genetic variants in TNNI3K are associated with supraventricular arrhythmias, conduction disease, and cardiomyopathy. Furthermore, studies in mice implicate the gene in cardiac hypertrophy, cardiac regeneration, and recovery after ischemia/reperfusion injury. Several new papers on TNNI3K have been published since the last overview, broadening the clinical perspective of TNNI3K variants and our understanding of the underlying molecular biology. We here provide an overview of the role of TNNI3K in cardiomyopathy and arrhythmia covering both a clinical perspective and basic science advancements. In addition, we review the potential of TNNI3K as a target for clinical treatments in different cardiac diseases.
Original languageEnglish
Article number6422
JournalInternational journal of molecular sciences
Issue number12
Publication statusPublished - 2 Jun 2021


  • Cardiac regeneration
  • Cardiomyopathy
  • Conduction disease
  • Hypertrophy
  • Myocardial infarction
  • Phosphorylation
  • Supraventricular arrhythmias
  • TNNI3K

Cite this